Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: A subgroup analysis of a phase 2 study

Gilles Salles, Stephen J. Schuster, Sven De Vos, Nina D. Wagner-Johnston, Andreas Viardot, Kristie A. Blum, Christopher R. Flowers, Wojciech J. Jurczak, Ian W. Flinn, Brad S. Kahl, Peter Martin, Yeonhee Kim, Sanatan Shreay, Matthias Will, Bess Sorensen, Madlaina Breuleux, Pier Luigi Zinzani, Ajay K. Gopal

Research output: Contribution to journalLetterpeer-review

41 Scopus citations
Original languageEnglish (US)
Pages (from-to)e156-e159
Issue number4
StatePublished - Mar 31 2017

ASJC Scopus subject areas

  • Hematology

Cite this